登记号 EUCTR2008-002672-95-NL 其他登记号 UMCNONCO200801 登记日期 2008-06-04 试验条件/适应症 Patients with a metastatic malignancy, treated with a registered oral angiogenetic inhibitor (tyrosine kinase inhibitor), who have progressive disease according to RECIST on CT-evaluation 试验干预/药物 Trade...
Lung cancer is the most common cause of cancer-related deaths globally. Although smoking-related lung cancers continue to account for the majority of diagnoses, smoking rates have been decreasing for several decades. Lung cancer in individuals who have never smoked (LCINS) is estimated to be the...
TherapyHypoxiaImmunoconjugatesInfluence of Diet and Obesity on Prevention or Promotion of DiseasesInnovative Approaches in Drug DiscoveryKidney Disease: From Pathophysiology to Novel Therapeutic ApproachesLatest Advances in Biomaterials for In-Situ HealingLiposomal Drug Delivery: Three Decades from the First ...